Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01833702 · ClinicalTrials.gov registry record

Use of a Mobile-based App for SCD Patients

A clinical trial of Chronic Pain and Sickle Cell Disease, sponsored by Duke University.

Completed
Registry status
21
Enrollment target
1
Study location

NCT01833702 is a study of Chronic Pain and Sickle Cell Disease that has completed, run by Duke University. The registered enrollment target is 21 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01833702, a study of Chronic Pain and Sickle Cell Disease, has completed, sponsored by Duke University.

COMPLETED
Registry status
21 participants
Enrollment target
1
Study location

Study Summary

The study will seek to enroll 100 sickle cell or thalassemia patients who are age 12 or older who have access to a smartphone or tablet with Internet access daily. The study will evaluate patient-reported comfort level with using a mobile device to record their pain levels, as well as adherence to recording these levels daily. The study will track patients' assessment of their pain, actions taken, and outcomes related to pain management and provider involvement. This study will attempt to collect information about differences in the use of two traditional pain assessment modes (verbal scale and paper) versus the use of a pain assessment tool on a mobile device in the form of a smartphone, tablet, or iPad with an Android or iOS operating system.

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2012-06
Est. Completion 2014-05

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT01833702

The ClinicalTrials.gov registry entry for NCT01833702 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 0 interventions.

NCT01833702 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT01833702 about?

NCT01833702 is a clinical study titled "Use of a Mobile-based App for SCD Patients". The study will seek to enroll 100 sickle cell or thalassemia patients who are age 12 or older who have access to a smartphone or tablet with Internet access daily. The study will evaluate patient-reported comfort level with using a mobile device to record their pain levels, as well as adherence to ...

What is the current status of trial NCT01833702?

This trial is currently completed. The enrollment target is 21 participants. The study started on 2012-06. Estimated completion is 2014-05.

What conditions does trial NCT01833702 study?

This clinical trial studies the following conditions: Chronic Pain, Sickle Cell Disease.

Who is sponsoring clinical trial NCT01833702?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01833702 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.